FOTEMUSTINE for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 21 adverse event reports in the FDA FAERS database where FOTEMUSTINE was used for Bone marrow conditioning regimen.
Most Reported Side Effects for FOTEMUSTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 66 | 25.0% | 9 | 16 |
| Disease progression | 38 | 14.4% | 8 | 0 |
| Acute myeloid leukaemia | 30 | 11.4% | 4 | 8 |
| Thrombocytopenia | 29 | 11.0% | 6 | 15 |
| Mucosal inflammation | 25 | 9.5% | 5 | 10 |
| Neutropenia | 24 | 9.1% | 6 | 10 |
| Product use in unapproved indication | 23 | 8.7% | 1 | 12 |
| Platelet count decreased | 22 | 8.3% | 1 | 1 |
| Neutrophil count decreased | 20 | 7.6% | 0 | 1 |
| Septic shock | 20 | 7.6% | 3 | 11 |
| White blood cell count decreased | 20 | 7.6% | 1 | 0 |
| Diffuse large b-cell lymphoma | 17 | 6.4% | 0 | 0 |
| Diffuse large b-cell lymphoma recurrent | 17 | 6.4% | 0 | 0 |
| Drug ineffective | 17 | 6.4% | 2 | 3 |
| Vomiting | 17 | 6.4% | 6 | 8 |
Other Indications for FOTEMUSTINE
Diffuse large b-cell lymphoma (77)
Non-hodgkin's lymphoma (20)
Autologous bone marrow transplantation therapy (14)
Glioblastoma (14)
Diffuse large b-cell lymphoma stage iv (12)
Metastatic malignant melanoma (10)
Stem cell transplant (10)
Intraocular melanoma (8)
Product used for unknown indication (8)
Allogenic bone marrow transplantation therapy (6)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
THYMOCYTE IMMUNE GLOBULIN NOS (742)